Cite

HARVARD Citation

    Miyashita, N. et al. (2022). Clinical efficacy of casirivimab-imdevimab antibody combination treatment in patients with COVID-19 Delta variant. Journal of infection and chemotherapy. 28 (9), pp. 1344-1346. [Online]. 
  
Back to record